- UroToday Home
- Recent Abstracts
- Urologic Oncology
Upper Tract Tumors
Fragmentation of cell-free DNA is induced by upper tract urothelial carcinoma-associated systemic inflammation.
October 12, 2020
Risk factors and survival outcomes of metachronous contralateral upper tract urothelial carcinoma.
October 8, 2020
The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder.
October 7, 2020
Future strategies to enhance kidney preservation in upper urinary tract urothelial carcinoma.
October 1, 2020
Risk stratification for upper tract urinary carcinoma.
September 28, 2020
UroVysion® predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study.
September 25, 2020
Novel treatment of upper tract urothelial carcinoma in situ with docetaxel in BCG refractory patients.
September 24, 2020
Controversies in management of the bladder cuff at nephroureterectomy.
September 23, 2020
The Impact of Ureteroscopy following Computed Tomography Urography in the Management of Upper Tract Urothelial Carcinoma.
September 21, 2020
Significance of p53, p27, Ki-67, E-cadherin, and HER2 expression in upper urinary tract urothelial carcinoma.
September 18, 2020
Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma.
September 17, 2020
Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
September 15, 2020
Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma.
September 14, 2020
The impact of hospital volume on short-term and long-term outcomes for patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma.
September 11, 2020
Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
September 10, 2020